Phytochemicals, bioactive compounds derived from plants, present a promising therapeutic approach for emerging infectious diseases, including rapidly spreading infections like COVID-19, highly pathogenic avian influenza (H5N1), dengue fever, multidrug-resistant tuberculosis (MDR-TB), and Zika virus infection. These compounds exhibit various pharmacological activities, including antiviral, antibacterial, antifungal, anti-inflammatory, and immunomodulatory effects. Their unique chemical structures offer novel mechanisms of action, potentially overcoming limitations of conventional drugs. For example, flavonoids, terpenoids, alkaloids, and saponins have demonstrated antiviral properties by inhibiting viral entry, replication, and host cell interactions. Despite their potential, challenges remain, including the need for standardized extraction, clinical validation, and optimization of bioavailability. Nevertheless, integrating phytochemicals with modern drug discovery technologies has the potential to accelerate the development of innovative therapies for emerging diseases. This chapter aims to explore the potential clinical applications of phytochemicals, with a focus on their mechanisms, recent advances in scientific evidence, and future prospects in alternative treatments for emerging infectious diseases.